Jyong Biotech Ltd. Ordinary Shares (MENS) — Financial Flexibility Index

Latest as of December 2024: -0.02x

Jyong Biotech Ltd. Ordinary Shares (MENS) has a Financial Flexibility Index of -0.02x as of December 2024. Free cash flow of $-913.00K (operating CF $-913.00K minus capex $0.00) represents 0% of total liabilities ($42.88 Million). Also explore MENS year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.02x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-913.00K
Operating CF − Capex

Total Liabilities

$42.88 Million
USD

Capital Expenditures

$0.00
USD

Jyong Biotech Ltd. Ordinary Shares Financial Flexibility Index (2020–2024)

Historical Financial Flexibility Index trend for Jyong Biotech Ltd. Ordinary Shares across 5 annual periods. Check Jyong Biotech Ltd. Ordinary Shares asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Annual Financial Flexibility Index for Jyong Biotech Ltd. Ordinary Shares (2020–2024)

Year-by-year free cash flow to debt coverage for Jyong Biotech Ltd. Ordinary Shares. For the full company profile including market capitalisation, see market value of Jyong Biotech Ltd. Ordinary Shares.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 -0.08x $-3.62 Million $-3.62 Million $42.88 Million ▼ -37.5%
2023 -0.06x $-2.60 Million $-2.60 Million $42.32 Million ▲ +13.4%
2022 -0.07x $-2.73 Million $-2.97 Million $38.38 Million ▼ -25.9%
2021 -0.06x $-1.85 Million $-1.98 Million $32.76 Million ▼ -80.9%
2020 -0.03x $-999.00K $-1.09 Million $32.05 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities